GRAPHENO, LLC — Department of Defense SBIR Phase II: SBIR PHASE II AWARD FOR PROPOSAL TITLED HALOVAX: CLAY NANOTUBE-BASED VACCINE DELIVERY PATC
GRAPHENO, LLC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,832 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Materials & Manufacturing, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Grapheno, LLC received over $1.2 million from the Department of Defense to develop HALOVAX, a patch using clay nanotubes to deliver HIV vaccine slowly over time. This technology aims to improve vaccine effectiveness through sustained release.
- Amount
- $1,299,832
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- LA
- Period
- 2026-04-08 → 2028-08-07
Technology domains
Description
SBIR PHASE II AWARD FOR PROPOSAL TITLED HALOVAX: CLAY NANOTUBE-BASED VACCINE DELIVERY PATCHES FOR THE SUSTAINED RELEASE OF AN HIV VACCINE